Certified by Founder Lodge
En Carta Diagnostics
France - Paris
START UP
1 Disclosed Funding Rounds $1,623,697
0 Participating Investments
-
Founded date
2022
-
Operating Status
Active
-
Last Funding Type
Seed
-
Company Type
For Profit
- Website
- Contact
- Social Links
Diagnostics for Better care, Everywhere.
En Carta Diagnostics is a synthetic-biology biotech company leveraging patented technologies to decentralise highly reliable molecular diagnostic s
| Date | Round | Raised | Participating Investors |
|---|---|---|---|
| May, 23 ,2024 | Pre-Seed | $1,623,697 |
Carmot Therapeutics, Inc.
Ozette Technologies
NAPIGEN, INC.
TrueBinding
Loopworm
Moonbounce | $12,000,000 | (Apr 7, 2026)
Insight Health AI, Inc. | $11,000,000 | (Apr 7, 2026)
Miravoice | $6,300,000 | (Apr 7, 2026)
Stipple Bio | $100,000,000 | (Apr 7, 2026)
Noon | $44,000,000 | (Apr 7, 2026)
